NLRP3 and type 2 diabetes mellitus: In this study, we have identified folic acid might be a putative drug for treating DCM through bioinformatics analysis, and experimentally proved that folic acid alleviated T2DM induced pyroptosis of cardiomyocytes by reducing NLRP3 inflammasome via the Hippo signaling pathway.